Skip to main content
Clinical Trials/NCT05198128
NCT05198128
Unknown
Not Applicable

Ovarian Hyper Stimulation Syndrome Using Calcium Infusion

Al-Azhar University0 sites200 target enrollmentMarch 1, 2022

Overview

Phase
Not Applicable
Intervention
Calcium intravenous infsuion
Conditions
Ovarian Hyperstimulation Syndrome
Sponsor
Al-Azhar University
Enrollment
200
Primary Endpoint
OHSS rate
Last Updated
4 years ago

Overview

Brief Summary

the incidence of OHSS and clinical outcomes after calcium IV infusion in high-risk women undergoing ART

Detailed Description

Among assisted reproductive technologies (ART), ovarian hyperstimulation syndrome (OHSS) is a serious iatrogenic complication affects up to 30% of women undergoing ART and caries high risks of morbidity and mortality. Women with age younger than 35 years, those with history of polycystic ovary syndrome (PCOS), or having a history of previous OHSS are more susceptible to develop OHSS

Registry
clinicaltrials.gov
Start Date
March 1, 2022
End Date
May 10, 2023
Last Updated
4 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Female

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Ahmed Said Ali

DR: ahmedsaidali, MCS CANDIDIATE

Al-Azhar University

Eligibility Criteria

Inclusion Criteria

  • infertile women aged 20 to 38 years. BMI ranged from 18 to
  • serum FSH within normal limits( 1-12IU /l) presented with ovarian response suggestive of being at risk of developing OHSS because of the presence of at least 15 follicles of 10 mm or greater on the day of hCG administration.

Exclusion Criteria

  • endocrinopathies. a systemic disease. and Insulin-dependent diabetes Thyroid disease using any medication (e.g., insulin-sensitizing drugs and GnRH antagonists. patients need coasting for high risk of OHSS. patients need cycle cancellation. severe male infertility requiring testicular sperm extraction.

Arms & Interventions

Calcium intravenous infusion

intravenous infusion of 10 % calcium gluconate 10 mL in 200 mL of physiologic saline on the day of ovum pickup, day 1,day 2, and day 3 after ovum pickup were administered in study group. Intravenous infusion was performed within 30 minutes

Intervention: Calcium intravenous infsuion

saline

0.9 % saline intravenous infusion

Intervention: 0.9 % saline

Outcomes

Primary Outcomes

OHSS rate

Time Frame: one year

ovarain hyperstimulation syndrome

Similar Trials